Growth in this Cell Culture Market is driven by the growing number of regulatory approvals for cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs). However, the lack of infrastructure for conducting cell-based research is a major factor restraining the growth of the overall cell culture market.
